United States Cardiovascular Devices Market Outlook to 2025 – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices and Others

1 Table of Contents 2

1.1 List of Tables 25

1.2 List of Figures 34

2 Introduction 37

2.1 What Is This Report About? 37

2.2 Cardiovascular Devices Market Segmentation 37

2.3 Definitions of Markets Covered in the Report 41

3 Cardiovascular Devices Market, United States 60

3.1 Cardiovascular Devices Market, United States, Revenue ($m), 2015-2025 60

3.2 Cardiovascular Devices Market, United States, Revenue Mix ($m), 2019 62

3.3 Cardiovascular Devices Market, United States, Category Contribution by Revenue ($m), 2019 63

3.4 Cardiovascular Devices Market, United States, Revenue ($m), 2015-2025 65

3.5 Cardiovascular Devices Market, United States, Volume (Units), 2015-2025 68

3.6 Cardiovascular Devices Market, United States, Volume (Units), 2015-2025 70

3.7 Cardiovascular Devices Market, United States, Company Share by Revenue ($m), 2019 73

4 Aortic and Vascular Graft Devices Market, United States 75

4.1 Aortic and Vascular Graft Devices Market, United States, Revenue Mix ($m), 2019 75

4.2 Aortic and Vascular Graft Devices Market, United States, Segment Contribution (%), 2019 76

4.3 Aortic and Vascular Graft Devices Market, United States, Revenue ($m), 2015-2025 77

4.3.1 Aortic Stent Grafts Market, United States, Revenue ($m), by Segment, 2015-2025 79

4.3.2 Vascular Grafts Market, United States, Revenue ($m), by Segment, 2015-2025 81

4.4 Aortic and Vascular Graft Devices Market, United States, Volume (Units), 2015-2025 83

4.4.1 Aortic Stent Grafts Market, United States, Volume (Units), by Segment, 2015-2025 85

4.4.2 Vascular Grafts Market, United States, Volume (Units), by Segment, 2015-2025 87

4.5 Aortic and Vascular Graft Devices Market, United States, Average Price ($), 2015-2025 89

4.6 Aortic and Vascular Graft Devices Market, United States, Distribution Share by Revenue ($m), 2019 91

4.7 Aortic and Vascular Graft Devices Market, United States, Company Share by Revenue ($m), 2019 92

5 Atherectomy Devices Market, United States 94

5.1 Atherectomy Devices Market, United States, Revenue Mix ($m), 2019 94

5.2 Atherectomy Devices Market, United States, Segment Contribution (%), 2019 95

5.3 Atherectomy Devices Market, United States, Revenue ($m), 2015-2025 96

5.3.1 Coronary Atherectomy Devices Market, United States, Revenue ($m), by Segment, 2015-2025 98

5.3.2 Lower Extremity Peripheral Atherectomy Devices Market, United States, Revenue ($m), by Segment, 2015-2025 100

5.4 Atherectomy Devices Market, United States, Volume (Units), 2015-2025 103

5.4.1 Coronary Atherectomy Devices Market, United States, Volume (Units), by Segment, 2015-2025 105

5.4.2 Lower Extremity Peripheral Atherectomy Devices Market, United States, Volume (Units), by Segment, 2015-2025 107

5.5 Atherectomy Devices Market, United States, Average Price ($), 2015-2025 110

5.6 Atherectomy Devices Market, United States, Distribution Share by Revenue ($m), 2019 112

5.7 Atherectomy Devices Market, United States, Company Share by Revenue ($m), 2019 113

6 Cardiac Assist Devices Market, United States 115

6.1 Cardiac Assist Devices Market, United States, Revenue Mix ($m), 2019 115

6.2 Cardiac Assist Devices Market, United States, Segment Contribution (%), 2019 116

6.3 Cardiac Assist Devices Market, United States, Revenue ($m), 2015-2025 117

6.3.1 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2015-2025 119

6.3.2 Mechanical Circulatory Support Devices Market, United States, Revenue ($m), by Segment, 2015-2025 121

6.3.3 Short-Term Circulatory Support Devices Market, United States, Revenue ($m), by Segment, 2015-2025 123

6.4 Cardiac Assist Devices Market, United States, Volume (Units), 2015-2025 125

6.4.1 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2015-2025 127

6.4.2 Mechanical Circulatory Support Devices Market, United States, Volume (Units), by Segment, 2015-2025 129

6.4.3 Short-Term Circulatory Support Devices Market, United States, Volume (Units), by Segment, 2015-2025 131

6.5 Cardiac Assist Devices Market, United States, Average Price ($), 2015-2025 133

6.6 Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), 2019 135

6.7 Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), 2019 136

7 Cardiac Rhythm Management Devices Market, United States 138

7.1 Cardiac Rhythm Management Devices Market, United States, Revenue Mix ($m), 2019 138

7.2 Cardiac Rhythm Management Devices Market, United States, Segment Contribution (%), 2019 139

7.3 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2015-2025 140

7.3.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2015-2025 143

7.3.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2015-2025 145

7.3.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2015-2025 148

7.4 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025 150

7.4.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2015-2025 153

7.4.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2015-2025 155

7.4.3 Pacemakers Market, United States, Volume (Units), by Segment, 2015-2025 158

7.5 Cardiac Rhythm Management Devices Market, United States, Average Price ($) , 2015-2025 160

7.6 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2019 162

7.7 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2019 163

8 Cardiovascular Prosthetic Devices Market, United States 165

8.1 Cardiovascular Prosthetic Devices Market, United States, Revenue Mix ($m), 2019 165

8.2 Cardiovascular Prosthetic Devices Market, United States, Segment Contribution (%), 2019 166

8.3 Cardiovascular Prosthetic Devices Market, United States, Revenue ($m), 2015-2025 167

8.3.1 Cardiac Valve Repairs Market, United States, Revenue ($m), by Segment, 2015-2025 169

8.4 Cardiovascular Prosthetic Devices Market, United States, Volume (Units), 2015-2025 171

8.4.1 Cardiac Valve Repairs Market, United States, Volume (Units), by Segment, 2015-2025 173

8.5 Cardiovascular Prosthetic Devices Market, United States, Average Price ($), 2015-2025 175

8.6 Cardiovascular Prosthetic Devices Market, United States, Distribution Share by Revenue ($m), 2019 176

8.7 Cardiovascular Prosthetic Devices Market, United States, Company Share by Revenue ($m), 2019 177

9 Cardiovascular Surgery Devices Market, United States 178

9.1 Cardiovascular Surgery Devices Market, United States, Revenue Mix ($m), 2019 178

9.2 Cardiovascular Surgery Devices Market, United States, Segment Contribution (%), 2019 179

9.3 Cardiovascular Surgery Devices Market, United States, Revenue ($m), 2015-2025 180

9.3.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2015-2025 182

9.3.2 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2015-2025 184

9.4 Cardiovascular Surgery Devices Market, United States, Volume (Units), 2015-2025 186

9.4.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2015-2025 188

9.4.2 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2015-2025 190

9.5 Cardiovascular Surgery Devices Market, United States, Average Price ($), 2015-2025 192

9.6 Cardiovascular Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2019 194

9.7 Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), 2019 195

10 Clot Management Devices Market, United States 197

10.1 Clot Management Devices Market, United States, Revenue Mix ($m), 2019 197

10.2 Clot Management Devices Market, United States, Segment Contribution (%), 2019 198

10.3 Clot Management Devices Market, United States, Revenue ($m), 2015-2025 200

10.3.1 Inferior Vena Cava Filters (IVCF) Market, United States, Revenue ($m), by Segment, 2015-2025 203

10.4 Clot Management Devices Market, United States, Volume (Units), 2015-2025 205

10.4.1 Inferior Vena Cava Filters (IVCF) Market, United States, Volume (Units), by Segment, 2015-2025 208

10.5 Clot Management Devices Market, United States, Average Price ($) , 2015-2025 210

10.6 Clot Management Devices Market, United States, Distribution Share by Revenue ($m), 2019 212

10.7 Clot Management Devices Market, United States, Company Share by Revenue ($m), 2019 213

11 Electrophysiology Devices Market, United States 215

11.1 Electrophysiology Devices Market, United States, Revenue Mix ($m), 2019 215

11.2 Electrophysiology Devices Market, United States, Segment Contribution (%), 2019 216

11.3 Electrophysiology Devices Market, United States, Revenue ($m), 2015-2025 217

11.3.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 219

11.3.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 221

11.3.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2015-2025 223

11.4 Electrophysiology Devices Market, United States, Volume (Units), 2015-2025 226

11.4.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2015-2025 228

11.4.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2015-2025 230

11.4.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2015-2025 232

11.5 Electrophysiology Devices Market, United States, Average Price ($), 2015-2025 235

11.6 Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), 2019 237

11.7 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2019 238

12 Interventional Cardiology Market, United States 240

12.1 Interventional Cardiology Market, United States, Revenue Mix ($m), 2019 240

12.2 Interventional Cardiology Market, United States, Segment Contribution (%), 2019 241

12.3 Interventional Cardiology Market, United States, Revenue ($m), 2015-2025 242

12.3.1 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 245

12.3.2 Coronary Stents Market, United States, Revenue ($m), by Segment, 2015-2025 247

12.3.3 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2015-2025 250

12.3.4 PTCA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 252

12.4 Interventional Cardiology Market, United States, Volume (Units), 2015-2025 254

12.4.1 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2015-2025 257

12.4.2 Coronary Stents Market, United States, Volume (Units), by Segment, 2015-2025 259

12.4.3 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2015-2025 262

12.4.4 PTCA Balloon Catheters Market, United States, Volume (Units), by Segment, 2015-2025 264

12.5 Interventional Cardiology Market, United States, Average Price ($) , 2015-2025 266

12.6 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2019 269

12.7 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2019 270

13 Peripheral Vascular Devices Market, United States 272

13.1 Peripheral Vascular Devices Market, United States, Revenue Mix ($m), 2019 272

13.2 Peripheral Vascular Devices Market, United States, Segment Contribution (%), 2019 273

13.3 Peripheral Vascular Devices Market, United States, Revenue ($m), 2015-2025 275

13.3.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2015-2025 278

13.3.2 Carotid and Renal Artery Stents Market, United States, Revenue ($m), by Segment, 2015-2025 280

13.3.3 Peripheral Embolic Protection Devices Market, United States, Revenue ($m), by Segment, 2015-2025 282

13.3.4 Peripheral Guidewires Market, United States, Revenue ($m), by Segment, 2015-2025 284

13.3.5 Peripheral Vascular Stents Market, United States, Revenue ($m), by Segment, 2015-2025 286

13.3.6 PTA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 288

13.3.7 PV Embolization Plugs and Coils Market, United States, Revenue ($m), by Segment, 2015-2025 290

13.3.8 Renal Denervation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 292

13.4 Peripheral Vascular Devices Market, United States, Volume (Units), 2015-2025 294

13.4.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2015-2025 297

13.4.2 Carotid and Renal Artery Stents Market, United States, Volume (Units), by Segment, 2015-2025 299

13.4.3 Peripheral Embolic Protection Devices Market, United States, Volume (Units), by Segment, 2015-2025 301

13.4.4 Peripheral Guidewires Market, United States, Volume (Units), by Segment, 2015-2025 303

13.4.5 Peripheral Vascular Stents Market, United States, Volume (Units), by Segment, 2015-2025 305

13.4.6 PTA Balloon Catheters Market, United States, Volume (Units), by Segment, 2015-2025 307

13.4.7 PV Embolization Plugs and Coils Market, United States, Volume (Units), by Segment, 2015-2025 309

13.4.8 Renal Denervation Catheters Market, United States, Volume (Units), by Segment, 2015-2025 311

13.5 Peripheral Vascular Devices Market, United States, Average Price ($) , 2015-2025 313

13.6 Peripheral Vascular Devices Market, United States, Distribution Share by Revenue ($m), 2019 317

13.7 Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), 2019 318

14 Prosthetic Heart Valves Market, United States 320

14.1 Prosthetic Heart Valves Market, United States, Revenue Mix ($m), 2019 320

14.2 Prosthetic Heart Valves Market, United States, Segment Contribution (%), 2019 321

14.3 Prosthetic Heart Valves Market, United States, Revenue ($m), 2015-2025 322

14.3.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 324

14.3.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 326

14.3.3 Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 328

14.4 Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2025 330

14.4.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 332

14.4.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 334

14.4.3 Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 336

14.5 Prosthetic Heart Valves Market, United States, Average Price ($), 2015-2025 338

14.6 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 2019 340

14.7 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2019 341

15 Overview of Key Companies in United States, Cardiovascular Devices Market 343

15.1 Medtronic Plc 343

15.1.1 Company Overview 343

15.2 Abbott Laboratories 343

15.2.1 Company Overview 343

15.3 Boston Scientific Corp 343

15.3.1 Company Overview 343

15.4 Edwards Lifesciences Corp 344

15.4.1 Company Overview 344

15.5 W. L. Gore & Associates Inc 344

15.5.1 Company Overview 344

15.6 Biosense Webster Inc 344

15.6.1 Company Overview 344

15.7 Abiomed Inc 345

15.7.1 Company Overview 345

15.8 Terumo Medical Corp 345

15.8.1 Company Overview 345

15.9 Cardiovascular Systems Inc 345

15.9.1 Company Overview 345

15.10 Koninklijke Philips NV 346

15.10.1 Company Overview 346

15.11 Cook Medical Inc 346

15.11.1 Company Overview 346

15.12 Biotronik AG 346

15.12.1 Company Overview 346

15.13 Cordis Corp 346

15.13.1 Company Overview 346

15.14 CR Bard Inc 347

15.14.1 Company Overview 347

16 Cardiovascular Devices Market Pipeline Products 348

17 Financial Deals Landscape 353

17.1 Acquisition 353

17.1.1 Lemaitre Vascular Acquires Artegraft 353

17.1.2 Smiths Medical Acquires Access Scientific 355

17.1.3 Dover to Acquire Em-tec 356

17.1.4 Hydrix Acquires

4.6% Stake in Angel Medical Systems (AngelMed) for USD1 Million 357

17.1.5 Terumo to Acquire Aortica 358

17.1.6 Merck Acquires FloDesign Sonics 359

17.1.7 HI-LEX to Acquire

66.7% Stake in EVAHEART for USD5.4 Million 360

17.1.8 Viant Medical Acquires Meraqi Medical 361

17.1.9 Baxter International to Acquire Cheetah Medical from HighCape Capital 362

17.1.10 Heraeus Medical Components to Acquire Via Biomedical 364

17.1.11 PreCheck Health Services to Acquire LD Technology and Medical Screening for USD15 Million 365

17.1.12 AtriCure to Acquire SentreHEART 366

17.1.13 Siemens Healthineers Acquires Corindus Vascular Robotics 368

17.2 Asset Transactions 370

17.2.1 Informed Data Systems (One Drop) Acquires Sano Intelligence 370

17.2.2 Vascular Graft Solutions Acquires Intellectual Property from Neograft Technologies 371

17.2.3 Integer Acquires Certain Assets of US BioDesign 372

17.2.4 Surmodics Acquires Intellectual Property Device Technology 373

17.3 Debt Offerings 374

17.3.1 Abbott Laboratories Raises USD650 Million in Public Offering of

1.4% Notes Due 2030 374

17.3.2 CryoLife Prices Private Placement of

4.250% Notes Due 2025 for USD100 Million 376

17.3.3 LivaNova USA Prices Private Placement of

3.00% Notes Due 2025 for USD250 Million 378

17.3.4 Stryker Prices Public Offering of

1.15% Notes Due 2025 for USD650 Million 380

17.3.5 Stryker Prices Public Offering of

1.95% Notes Due 2030 for USD1 Billion 382

17.3.6 Stryker Prices Public Offering of

2.9% Notes Due 2050 for USD650 Million 384

17.3.7 Teleflex Prices Private Placement of

4.25% Notes Due 2028 for USD500 Million 386

17.3.8 Boston Scientific Raises USD1.2 Billion in Public Offering of

2.65% Senior Notes due 2030 387

17.3.9 Boston Scientific Raises USD500 Million in Public Offering of

1.9% Senior Notes due 2025 389

17.3.10 Becton Dickinson Raises USD750 Million in Public Offering of

2.823% Notes Due 2030 391

17.3.11 Becton Dickinson Raises USD750 Million in Public Offering of

3.794% Notes Due 2050 393

17.3.12 Intact Vascular Raises USD13.5 Million in Debt Offering 395

17.3.13 General Electric Prices USD1.25 Billion in Public Offering of

3.62% Notes due 2030 396

17.3.14 General Electric Prices USD1.5 Billion in Public Offering of

4.25% Notes Due 2040 398

17.3.15 General Electric Prices USD2.25 Billion in Public Offering of

4.35% Notes due 2050 400

17.3.16 Baxter International Raises USD500 Million in Private Placement of

3.95% Senior Notes Due 2030 402

17.3.17 Baxter International Raises USD750 Million in Private Placement of

3.75% Senior Notes Due 2025 403

17.3.18 Integra LifeSciences Prices Private Placement of

0.5% Convertible Senior Notes Due 2025 for USD500 Million 404

17.3.19 MRI Interventions Raises USD17.5 Million in Private Placement of Notes 406

17.3.20 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 408

17.3.21 Stryker Raises USD881.3 Million in Public Offering of

0.75% Notes Due 2029 410

17.3.22 Stryker Raises USD936.4 Million in Public Offering of

0.25% Notes Due 2024 412

17.3.23 Boston Scientific Raises USD999.2 Million in Public Offering of

0.625% Notes Due 2027 414

17.3.24 MiRTLE Medical Raises USD0.2 Million in Debt Funding 416

17.4 Equity Offerings 417

17.4.1 Aspira Womens Health to Raise USD11 Million in Private Placement of Shares 417

17.4.2 Bellerophon Therapeutics Files Registration Statement for Public Offering of Securities for up to USD150 Million 418

17.4.3 BioSig Technologies Raises USD17.5 Million in Registered Direct Offering of Shares 420

17.4.4 Avinger Raises USD5.4 Million in Public Offering of Shares 421

17.4.5 Shockwave Medical Prices Public Offering of Shares for USD77.8 Million 423

17.4.6 Cardiovascular Systems Prices Public Offering of Shares for USD125 Million 425

17.4.7 Cardiovascular Systems Announces Exercise of Over-Allotment Option of Public Offering of Shares for USD143.7 Million 427

17.4.8 Osprey Medical to Raise USD1.8 Million in Private Placement of CDI’s 429

17.4.9 InspireMD Raises USD11.5 Million in Public Offering of Units 430

17.4.10 Hancock Jaffe Lab to Raise USD0.97 Million in Public Offering of Shares 432

17.4.11 Penumbra Prices Public Offering of Shares for USD125 Million 433

17.4.12 SurModics Plans to Raise up to USD200 Millon in Public Offering of Securities 435

17.4.13 Boston Scientific Raises USD1 Billion in Public Offering of Shares 436

17.4.14 Boston Scientific Raises USD1 Billion in Public Offering of

5.5% Mandatory Convertible Preferred Stock 438

17.4.15 Lemaitre Vascular Files Registration Statement for Public Offering of Securities for up to USD200 Million 440

17.4.16 Becton Dickinson Raises USD1.5 Public Offering of Shares 442

17.4.17 Becton Dickinson Raises USD1.5 Billion in Public Offering of Depositary Shares 444

17.4.18 Bellerophon Therapeutics Raises USD15 Million in Private Placement of Shares 447

17.4.19 Inari Medical Raises USD179.2 Million in IPO of Shares 449

17.4.20 Bellerophon Therapeutics Raises USD28.8 Million in Public Offering of Shares 451

17.4.21 AtriCure Prices Public Offering of Shares for USD175 Million 453

17.4.22 Silk Road Medical Raises USD305.4 Million in Public Offering of Shares, Including Underwriters’ Exercise of Overallotment Option 455

17.4.23 CHF Solutions Raises USD1.7 Million in Private Placement of Shares and Warrants 457

17.4.24 PAVmed Raises USD4.11 Million in Equity Offering 459

17.4.25 Hancock Jaffe Laboratories to Raise USD1 Million in Registered Direct Offering 460

17.4.26 Lyra Therapeutics Raises USD64 Million in IPO of Shares 461

17.4.27 Avinger Raises USD3.6 Million in Public Offering of Shares, Including Underwriters Exercise of Over Allotment Option 463

17.4.28 Bellerophon Raises USD15.3 Million in Private Placement of Shares 465

17.4.29 CHF Solutions Prices Private Placement of Shares and Warrants for USD2.2 Million 466

17.4.30 Precipio Files Registration Statement for Public Offering of Securities up to USD50 Million 468

17.4.31 CHF Solutions Raises USD1.3 Million in Private Placement of Shares and Warrants 469

17.4.32 Stereotaxis Files Registration Statement for Public Offering of Securities for up to USD100 Million 471

17.4.33 T2 Biosystems Plans to Raise up to USD95 Million in Public Offering of Shares 472

17.4.34 Hancock Jaffe Labs Raises USD0.7 Million in Private Placement of Securities 473

17.4.35 Imricor Medical Systems Raises USD13.5 Million in Private Placement of Shares 474

17.4.36 Imricor Medical Systems Plans to Raise USD0.3 Million in Private Placement of Shares 476

17.4.37 BioSig Technologies Raises USD10 Million in Public Offering of Shares 477

17.4.38 VADovations Secures Funds through Financing 478

17.4.39 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 479

17.4.40 Avinger Raises USD4.5 Million in Public Offering of Shares 480

17.4.41 CHF Solutions Raises USD9.66 Million in Public Offering 482

17.4.42 SI-Bone Prices USD92.45 Million Public Offeirng of Shares 484

17.4.43 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 486

17.4.44 Precipio Plans to Raise up to USD1.7 Million in Public Offering of Shares 488

17.4.45 Organogenesis Prices USD45 Million Public Offering of Shares 489

17.4.46 Shockwave Medical Prices USD89.9 Million Public Offering of Shares 491

17.4.47 SI-Bone Plans to Raise up to USD200 Million in Public Offering of Securities 493

17.4.48 PAVmed to Raise USD14 Million in Private Placement 494

17.4.49 CHF Solutions Raises USD1.4 Million in Private Placement of Shares 495

17.4.50 CHF Solutions Raises USD0.7 Million in Private Placement of Shares 496

17.4.51 BioSig Technologies Raises USD0.7 Million in Private Placement of Securities 497

17.4.52 InspireMD Raises USD5 Million in Public Offering of Units 498

17.4.53 Canon Medical Systems Invests in FemtoDx 500

17.4.54 iRhythm Technologies Raises USD115 Million in Public Offering of Shares 501

17.4.55 Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities 503

17.4.56 Avinger Raises USD4.5 Million in Public Offering of Shares 504

17.4.57 Endologix Plans to Raise up to USD75 Million in Public Offering of Shares 506

17.4.58 Stereotaxis Raises USD25 Million in Private Placement of Common Stock 507

17.4.59 Silk Road Medical Raises USD190.7 Million in Public Offering of Shares 509

17.4.60 BioSig Technologies Raises USD3.3 Million in Financing 511

17.4.61 Access Scientific Raises USD20 Million in Private Placement of Shares 512

17.4.62 T2 Biosystems to Raise up to USD30 Million in Public offering of Shares 513

17.4.63 Nuvectra Plans to Raise up to USD25 Million in Public Offering of Shares 514

17.4.64 Cytosorbents Increases Public Offering of Shares to up to USD50 Million 515

17.5 Grants 516

17.5.1 Pediatric ECMO Oxygenator with Integrated Monitoring 516

17.5.2 Noninvasive Home Assessment of Cardiac Filling Pressure to Identify Heart Failure Patients at High Risk for Readmission 517

17.5.3 A Novel Synthetic Vascular Graft Capable of Minimally Invasive Controlled Expansion for Vascular Reconstruction Model 518

17.5.4 Biodegradability and Biocompatibility of a Shape Memory Polymer Wrap to Improve Saphenous Vein Graft Patency in Peripheral and Coronary Artery Bypass Grafting Surgeries 519

17.5.5 A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus 520

17.5.6 Pediatric Implantable Low-Shear Pulsatile Blood Pump with Physiologic Sensing and Control 521

17.5.7 Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients 522

17.5.8 BlueBox: A Complete Code Blue Data Recorder, Phase II 523

17.5.9 Internship experience led by a mentor to assist in research of the pre-clinical safety of the Endoscopic Venous Valve System (EVVS). 524

17.5.10 HLS-Diagnostic Balloon in Novel Venous Disease Model 525

17.5.11 Balloon Angioplasty Inflation Device 526

17.5.12 Precise Minimally InvasiveTreatment of VT Using Non-invasive Mapping. 527

17.5.13 A Biodegradable Vascular Coupling Device for End-to-End Anastomosis 528

17.5.14 Development of a hybrid transcatheter mitral valve replacement and repair device 529

17.5.15 Small Peripheral Vessel Graft 530

17.5.16 Adding SpO2 and Hemoglobin Determinations to Non-Invasive Hemodynamic Monitoring for Healthy Independent Living 531

17.5.17 Automated Assessment of Leptomeningeal Collaterals on CT Angiograms 532

17.5.18 Device for Treatment of Cardiac No-Option Patients 533

17.5.19 Using Augmented Reality To Make Cardiac Ablation Procedures Simpler and Safer 534

17.5.20 Cardiac Ventricular Assist Catheter 535

17.5.21 EVVS: Endoscopic Venous Valve System 536

17.5.22 CLOSURE DEVICE FOR TRANSCAVAL ACCESS TO THE ABDOMINAL AORTA 537

17.5.23 Novel Leaflet Biomaterial for Pulmonary Artery Valve 538

17.6 Merger 539

17.6.1 Hancock Jaffe Laboratories Plans to Merge with Catheter Precision 539

17.7 Partnerships 540

17.7.1 Mayo Clinic Enters into Collaboration with Ultromics to Assess Patients Diagnosed with COVID-19 540

17.7.2 AliveCor Enters into Partnership with Emory University School of Medicine and Georgia Institute of Technology 541

17.7.3 Gore Innovation Center Enters into Collaboration with Moray Medical 543

17.7.4 VADovations Enters into Licensing Agreement with Mayo Clinic 544

17.7.5 Feedback Enters into Licensing Agreement with Imaging Engineering 545

17.7.6 Astellas and iota Biosciences Enter into Research Agreement 546

17.7.7 BioSig Technologies Enters into Licensing Agreement with Mayo Clinic 547

17.7.8 iRhythm Technologies Enters into Agreement with Verily Life Sciences 548

17.7.9 B. Braun Interventional Systems Enters into Distribution Agreement with Nano4imaging 550

17.7.10 NanoVibronix Expands Licensing Agreement with Ideal Medical 551

17.8 Private Equity 552

17.8.1 Stereotaxis to Raise USD15 Million in Private Placement of Shares 552

17.8.2 Decathlon Capital Partners Invests in Cirtec Medical 553

17.8.3 Osprey Medical Raises USD6.2 Million in Entitlement Offer of CDI 554

17.8.4 JenaValve Technology Raises USD50 Million in Equity Financing 556

17.8.5 Ascyrus Medical Raises Funds through Equity Financing 558

17.8.6 Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital 559

17.8.7 Consortium of Investors Acquires eResearchTechnology 560

17.8.8 Blackstone Group and Cinven May Bid for Smiths Medical 562

17.9 Venture Financing 564

17.9.1 Protaryx Medical Raises USD3.2 Million in Seed Financing 564

17.9.2 Protaryx Medical Raises USD5.1 Million in Series A Financing 565

17.9.3 Avive Solutions Raises USD7 Million in Venture Financing 566

17.9.4 Okami Medical Raises USD7.2 Million in Series D Financing 567

17.9.5 Foldax Raises USD20 Million in Series D Financing 568

17.9.6 Vascular Dynamics Raises USD33 Million in Venture Financing 570

17.9.7 Peca Labs Raises USD0.6 Million in Venture Financing 571

17.9.8 Arterys Raises USD28 Million in Series C Financing 572

17.9.9 Artio Medical to Raise Funds through Venture Financing 574

17.9.10 Flow Forward Medical to Raise Funds through Venture Financing 575

17.9.11 Thermedical Raises Additional USD8 Million in Venture Financing 576

17.9.12 Ionetix Raises Additional USD10.5 Million in Venture Financing 577

17.9.13 Cardio Flow Raises USD1.2 Million in Venture Financing 578

17.9.14 Nectero Medical to Raise USD1.5 Million in Venture Financing 579

17.9.15 Saranas Raises USD1.7 Million in Venture Financing 580

17.9.16 AtaCor Medical Raises USD25 Million in Series B Financing 581

17.9.17 Efferent Labs to Raise USD3 Million in Venture Financing 582

17.9.18 Vida Diagnostics Raises USD2 Million in Second Tranche of Series C Financing 583

17.9.19 InnAVasc Medical Raises USD0.4 Million in Venture Financing 584

17.9.20 Piccolo Medical Raises USD1 Million in Venture Financing 585

17.9.21 Artio Medical Raises Additional USD8.8 Million in Series A Financing 586

17.9.22 RCE Technologies Raises Additional Funds through Venture Financing 587

17.9.23 Vida Diagnostics Raises USD11 Million in Initial Tranche of Series C Financing 588

17.9.24 Artio Medical to Raise Funds through Venture Financing 590

17.9.25 Flow Forward Medical to Raise Funds through Venture Financing 591

17.9.26 Centerline Biomedical Raises USD10 Million in Venture Financing 592

17.9.27 NuPulseCV Raises USD2.1 Million in Venture Financing 593

17.9.28 CardioWise Raises USD0.34 Million in Venture Financing 594

17.9.29 Element Science Raises USD145.6 Million in Series C Financing 595

17.9.30 Supira Medical Raises USD35 Million in Series B Financing 597

17.9.31 BioStable Science & Engineering Raises Funds through Initial Closing of Series C Financing 598

17.9.32 Maximum Fidelity Surgical Raises USD0.08 Million in Venture Financing 599

17.9.33 InterRad Medical Raises Additional USD3.5 Million in Venture Financing 600

17.9.34 Bardy Diagnostics (BardyDx) Raises USD12.5 Million in Venture Financing 601

17.9.35 S4 Medical Raises Funds through Venture Financing 602

17.9.36 Cardiac Insight Raises USD8 Million in Series D Financing 603

17.9.37 Aria CV Raises USD31 Million in Series B Financing 604

17.9.38 NeuroTronik Raises USD0.1 Million in Venture Financing 606

17.9.39 Emboline Raises USD5 Million in Financing 607

17.9.40 Lyra Therapeutics Raises USD30 Million in Series C Financing 608

17.9.41 Vascular Therapies Raises USD17.3 Million in Financing 610

17.9.42 Scinovia Raises Additional USD1 Million in Venture Financing 611

17.9.43 Native Cardio Raises Additional USD0.15 Million in Venture Financing 612

17.9.44 RCE Technologies Raises Additional Funds through Venture Financing 613

17.9.45 Aruga Technologies Raises Funds through Venture Financing 614

17.9.46 SentiAR Raises USD3 Million in Venture Financing 615

17.9.47 Cardio Flow Raises Additional USD1.7 Million in Venture Financing 616

17.9.48 Cardio Flow Raises USD0.4 Million in Venture Financing 617

17.9.49 Aria CV Raises USD0.7 Million in Venture Financing 618

17.9.50 Contego Medical Raises USD22.3 Million in Venture Financing 619

17.9.51 VDYNE Raises USD6.8 Million in Venture Financing 620

17.9.52 NeuroTronik Raises USD0.12 Million in Venture Financing 621

17.9.53 I-V Access Technology Raises USD0.05 Million in Venture Financing 622

17.9.54 Adona Medical Raises USD2.5 Million in Seed Financing 623

17.9.55 Treasure Valley Urology Raises USD0.04 Million in Venture Financing 624

17.9.56 VADovations Raises USD5 Million in Venture Financing 625

17.9.57 Peerbridge Health Secures USD11 in Venture Funding 626

17.9.58 Heart Test Labs Raises USD0.14 Million in Venture Financing 627

17.9.59 Cardia Raises USD0.36 Million in Venture Financing 628

17.9.60 Vascular Therapies Raises USD7.4 Million in Venture Financing 629

17.9.61 Transverse Medical Raises USD0.14 Million in Venture Financing 630

17.9.62 Sonavex Raises USD3 Million in Financing 631

17.9.63 Gregor Diagnostics Raises USD1 Million in Venture Financing 632

17.9.64 AliveCor Raises USD5.8 Million in Venture Financing 633

17.9.65 Sonavex Raises USD1.8 Million in Venture Funding 634

17.9.66 MiRTLE Medical Secures USD0.534 Million in Funding Round 635

17.9.67 4C Medical Technologies Raises USD8.2 Million in Venture Financing 636

17.9.68 Eko Devices Raises USD20 Million in Series B Financing 637

17.9.69 Healionics Raises USD4.5 Million in Financing Round 639

17.9.70 HDL Therapeutics Raises USD3 Million in Venture Financing 640

17.9.71 NeuroClear Technologies Raises USD3.7 Million in Seed Funding 641

17.9.72 Imricor Medical Systems Raises USD0.6 Million in Venture Financing 642

17.9.73 EBR Systems Raises USD30 Million in Venture Financing 643

17.9.74 Access Vascular Raises USD5.6 Million in Venture Financing 645

17.9.75 Forest Devices Raises Funds through Venture Financing 646

17.9.76 Ventriflo Raises USD10 Million in Series A Financing 647

17.9.77 Avicena to Raise USD14 Million in Venture Financing 648

17.9.78 NeuroClear Technologies Raises USD3.3 Million in Venture Financing 649

17.9.79 Cardiac Insight Raises USD4.7 Million in Venture Financing 650

17.9.80 Access Point Technologies to Raise USD3 Million in Venture Financing 651

17.9.81 VIDA Diagnostics Raises Funds through Venture Financing 652

17.9.82 Ablacon Raises USD12 Million in Venture Financing 653

17.9.83 Bioventrix Raises USD2.5 Million in Venture Financing 654

17.9.84 ReThink Medical Raises Funds through Venture Financing 655

17.9.85 Ostial Raises USD2.7 Million in Venture Financing 656

17.9.86 Orchestra BioMed Raises USD34 Million in Series B-1 Financing 657

17.9.87 Procyrion Raises USD30 Million in Series D Financing 659

17.9.88 EIR (HeartHero) Raises USD0.5 Million in Series A Financing 660

18 Recent Developments 661

18.1 Corporate Communications 661

18.1.1 Jun 25, 2020: Okami Medical raises funds to support technology development 661

18.1.2 Jun 02, 2020: Caretaker Medical receives new investment from Philips and others to enhance wireless ‘Beat by Beat’ blood pressure and continuous vital signs platform for remote and ‘Clinically-Distanced’ Patient Monitoring 661

18.1.3 May 18, 2020: Habayeb named Sr VP of GE and president & CEO of GGO 662

18.1.4 May 04, 2020: CytoSorbents promotes Vincent J. Capponi to president 663

18.1.5 Mar 23, 2020: McKesson announces executive vice president and chief strategy and business development officer to step down 663

18.1.6 Mar 04, 2020: Element Science raises $145.6m through Series C funding round 664

18.1.7 Mar 04, 2020: GE Nominates Ashton Carter to the Board of Directors 664

18.1.8 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference 665

18.1.9 Mar 03, 2020: Exelixis announces George A. Scangos, Ph.D. to retire from its Board of Directors 666

18.1.10 Mar 03, 2020: Orchestra BioMed adds seasoned biotech executive Pamela Yanchik Connealy to Board of Directors 667

18.1.11 Mar 02, 2020: Stryker announces new Investor Relations leader 668

18.1.12 Feb 28, 2020: NeuroVasc Technologies gets $34m funding from Wego Group 668

18.1.13 Feb 26, 2020: Aria CV completes Series B round to fund clinical study in US 669

18.1.14 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum 669

18.1.15 Feb 17, 2020: Hershey Medical Center becomes first in region to offer latest Edwards Sapien heart valve device 670

18.1.16 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement 671

18.1.17 Feb 12, 2020: Carolina Dybeck Happe to join GE as Chief Financial Officer on March 1, 2020 671

18.1.18 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer 671

18.1.19 Feb 06, 2020: JenaValve raises equity financing funds for clinical programme 672

18.1.20 Feb 06, 2020: Syntactx appoints Dorothy Abel as Vice President, Regulatory Strategy 672

18.1.21 Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer 673

18.1.22 Feb 06, 2020: Spaulding Clinical announces COO Cassandra Erato will succeed Randy Spaulding as CEO 673

18.1.23 Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs 674

18.1.24 Feb 03, 2020: Eisai expands leadership team in the US with the appointment of two key leaders 674

18.1.25 Jan 31, 2020: Emboline completes $5m bridge round of financing 675

18.1.26 Jan 28, 2020: Inari Medical appoints Cynthia Lucchese and Catherine Szyman to the company’s Board of Directors 676

18.1.27 Jan 28, 2020: 3M Company: Departure of directors or certain officers 677

18.1.28 Jan 24, 2020: USF Health-TGH first in Florida using new organ transplant technology designed to save more lives 677

18.1.29 Jan 24, 2020: King Systems issues recall of King Vision Video Laryngoscope Video Adapter Size 1/2 679

18.1.30 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 679

18.1.31 Jan 21, 2020: StimGuard Strengthens executive team with addition of Stephen Deitsch as Chief Financial Officer 680

18.1.32 Jan 16, 2020: Audax Private Debt provides financing to support Olympus Partners Investment in Soliant Health 680

18.1.33 Jan 14, 2020: Leading national health plan selects Inovalon’s cloud-based pharmacy platform 681

18.1.34 Jan 14, 2020: Bioclinica announces additions to software solutions leadership 682

18.1.35 Jan 13, 2020: T2 Biosystems promotes Tony Pare to Chief Commercial Officer 682

18.1.36 Jan 13, 2020: Bardy Diagnostics names Ed Vertatschitsch as Chief Operating Officer and announces additions to the leadership team 683

18.1.37 Jan 10, 2020: E4 Paves the road towards a revolutionary era of environmental friendly medicines 684

18.1.38 Jan 10, 2020: Cardiva Medical appoints Jeri Hilleman to the company’s Board of Directors 686

18.1.39 Jan 09, 2020: T2 Biosystems appoints industry veteran John Sperzel as chief executive officer 686

18.1.40 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. 687

18.1.41 Jan 07, 2020: Cleveland Clinic appoints Lara Jehi, M.D., Chief Research Information Officer 687

18.1.42 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 688

18.1.43 Dec 20, 2019: Bioclinica announces senior leadership change 689

18.1.44 Dec 19, 2019: Oxurion NV to provide update on THR-149 689

18.1.45 Dec 16, 2019: MiMedx Announces addition of Peter M. Carlson 690

18.1.46 Dec 16, 2019: Avinger appoints Healthcare Veteran Tamara Elias, MD, to board of directors 690

18.1.47 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 691

18.1.48 Dec 10, 2019: New Menarini CELLSEARCH studies to be presented at San Antonio Breast Cancer Symposium 691

18.1.49 Dec 09, 2019: McKesson appoints Nancy Flores as executive vice president, chief information and chief technology officer 693

18.1.50 Dec 06, 2019: Gilero opens new design center in Southern California 694

18.1.51 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business 694

18.1.52 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 695

18.1.53 Dec 04, 2019: Impulse Dynamics raises funds towards Optimizer Smart System 696

18.1.54 Dec 04, 2019: SI-BONE names Jeryl Hilleman to Board of Directors 696

18.1.55 Dec 04, 2019: AtriCure names two industry veterans to Board of Directors 697

18.1.56 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 697

18.1.57 Dec 02, 2019: StimGuard names executive management team to complete market readiness for the world’s first office based OAB stimulator system 698

18.1.58 Dec 01, 2019: Intelerad emphasizes interoperability, extends reach of Clario SmartWorklist 699

18.1.59 Nov 26, 2019: MiMedx names William “Butch” Hulse as General Counsel and Secretary 700

18.1.60 Nov 26, 2019: CVR Medical announces Peter Bakema resigns as CEO, President And Chairman of Board 700

18.1.61 Nov 25, 2019: GE names Carolina Dybeck Happe as Chief Financial Officer 701

18.1.62 Nov 25, 2019: Maggie Yuen appointed Chief Financial Officer of Penumbra 701

18.1.63 Nov 21, 2019: Cleveland Clinic names James Merlino, M.D., chief clinical transformation officer 702

18.1.64 Nov 20, 2019: Former Cleveland Clinic CEO Toby Cosgrove, MD, joins InnovaHealth Partners as Senior Advisor 703

18.1.65 Nov 19, 2019: Lyra Therapeutics appoints Bradford Smith to its Board of Directors 704

18.1.66 Nov 14, 2019: Gofire launches patented, metered-dose inhaler to vaporization market seeking safe, accurate dose control 704

18.1.67 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 706

18.1.68 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 707

18.1.69 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 707

18.1.70 Nov 08, 2019: ALK to present new phase 3 data demonstrating the efficacy and safety of Ragwitek (short ragweed pollen allergen extract tablet for sublingual use 12 Amb a 1-U) Sublingual Allergy Immunotherapy (SLIT)-Tablets in pediatric patients at ACAAI 2019 Annual Scientific Meeting 708

18.1.71 Nov 08, 2019: Big Lots raises $3 million during its fall “Give Big for Kids” campaign for Nationwide Children’s Hospital 710

18.1.72 Nov 06, 2019: Dr. Eric Mortensen to leave CytoSorbents at year end 710

18.1.73 Nov 06, 2019: Sasha Gentling, CFA Joins BioSig as Director of business development 711

18.1.74 Nov 04, 2019: CytoSorbents announces additions to its international clinical team 711

18.1.75 Nov 01, 2019: Orthofix appoints Jon Serbousek as President and Chief Executive Officer 712

18.1.76 Oct 31, 2019: Harvard Bioscience Announces Executive Appointment 713

18.1.77 Oct 30, 2019: OmniGuide Holdings hires Giorgio Brusa as VP Global Marketing and Matthew Rice as Managing Director, OmniGuide Surgical Strategic Business Unit 713

18.1.78 Oct 29, 2019: Abbott to build medical device manufacturing facility in Indiana 714

18.1.79 Oct 29, 2019: BioSig appoints Andrew Ballou as Vice President of Investor Relations 715

18.1.80 Oct 28, 2019: ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at AACR-NCI-EORTC Annual Conference 715

18.1.81 Oct 22, 2019: AngioDynamics announces departure of CFO and appointment of interim CFO 716

18.1.82 Oct 21, 2019: Harvard Bioscience announces Executive appointment 717

18.1.83 Oct 18, 2019: McKesson’s Board of Directors appoints Maria Martinez as new independent Director 717

18.1.84 Oct 15, 2019: Miach Orthopaedics names Michael J. McNulty Vice President of Sales and Marketing 718

18.1.85 Oct 11, 2019: TherapeuticsMD announces presentations on ANNOVERA at the 2019 Annual Meeting of the American Society for Reproductive Medicine 718

18.1.86 Oct 10, 2019: Atrium Health welcomes new Senior Vice President, Enterprise Strategy and Planning 719

18.1.87 Oct 08, 2019: CardioWise named a top-ten finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub 720

18.1.88 Oct 04, 2019: VIDA expands Board, announcing Erkan Akyuz as Independent Director 720

18.1.89 Oct 01, 2019: Sensydia Appoints Anthony Arnold as President and Chief Executive Officer 721

18.1.90 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 722

18.1.91 Sep 26, 2019: Catabasis Pharmaceuticals and the Jain Foundation announce a preclinical research collaboration to study Edasalonexent in Dysferlinopathy 722

18.1.92 Sep 26, 2019: Eko secures funds to develop AI tool for cardiac screening 723

18.1.93 Sep 26, 2019: Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors 724

18.1.94 Sep 26, 2019: BD announces leadership succession plan 724

18.1.95 Sep 25, 2019: Ron Smith Elected Board Chairman for AdventHealth 726

18.1.96 Sep 24, 2019: Jaguar Health to host investor call to provide updates regarding development of Mytesi for the potential follow-on indication of cancer therapy-related diarrhea 727

18.1.97 Sep 23, 2019: CONMED adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors 728

18.1.98 Sep 20, 2019: Nuvectra appoints Jennifer Kosharek as chief financial officer 728

18.1.99 Sep 20, 2019: MiMedx announces resignation of board member 729

18.1.100 Sep 19, 2019: JenaValve Technology strengthens senior leadership team in clinical affairs and operations 729

18.1.101 Sep 16, 2019: Stereotaxis announces CFO transition 730

18.1.102 Sep 16, 2019: BioVentrix announces the appointment of Pedro Marques as VP of Sales in Europe 730

18.1.103 Sep 16, 2019: Hancock Jaffe appoints Global Healthcare Executive Matthew Jenusaitis and Financial and Medical Reimbursement Expert Robert Gray to its board of directors 731

18.1.104 Sep 12, 2019: IntriCon announces appointment of Craig Sandbulte as vice president of quality and regulatory Affairs; Succeeds Greg Gruenhagen upon retirement 732

18.1.105 Sep 04, 2019: Mereo BioPharma announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting 733

18.1.106 Sep 04, 2019: Lyra Therapeutics appoints Ann Merrifield to its Board of Directors 734

18.1.107 Sep 04, 2019: CHF Solutions appoints world-renowned heart failure cardiologist, Maria Rosa Costanzo, M.D. to company’s board of directors 735

18.1.108 Sep 04, 2019: Harvard Bioscience elects Alan Edrick to Board of Directors 735

18.1.109 Sep 04, 2019: Odyssey Group International appoints new Board Member 736

18.1.110 Aug 29, 2019: Sri Kosaraju promoted to President and CFO of Penumbra 736

18.1.111 Aug 28, 2019: Rose Kelly-Falls named global leader of procurement and supply chain for Cook Medical 737

18.1.112 Aug 26, 2019: Priya Chaturvedi, Ph.D., appointed Vice President of Global Clinical Quality Assurance at Eisai 737

18.1.113 Aug 23, 2019: CVR Medical announces board vacancies 737

18.1.114 Aug 23, 2019: CVR Medical announces interim CFO 738

18.1.115 Aug 21, 2019: Rebiotix and Karolinska Institutet expand partnership to shape the future of microbiome research 738

18.1.116 Aug 20, 2019: Nurx launches in Nebraska, leveraging telemedicine to provide affordable and convenient access to healthcare 738

18.1.117 Aug 20, 2019: FDA accepts New Drug Application for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor combination treatment 739

18.1.118 Aug 20, 2019: Dr. Alfred Coats appointed chairman of the Board at Millar 740

18.1.119 Aug 20, 2019: Cleveland Clinic Akron General designated a Thrombectomy-Capable Stroke Center 741

18.1.120 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 741

18.1.121 Aug 19, 2019: Matt Mesnik, MD, named chief medical officer for Spok 742

18.1.122 Aug 13, 2019: SI-BONE: Departure of directors or certain officers 743

18.1.123 Aug 12, 2019: Stryker announces commercial structure realignment 743

18.1.124 Aug 07, 2019: Study demonstrates reduction in mortality using Masimo Noninvasive, Continuous Hemoglobin (SpHb) and Pleth Variability Index (PVi) Monitoring 743

18.1.125 Aug 07, 2019: OSI Systems receives $6 million order for patient monitoring solutions 745

18.1.126 Aug 07, 2019: Dean Scarborough and John Weiland to join Cardinal Health’s Board of Directors 745

18.1.127 Aug 06, 2019: BioVentrix announces key additions to leadership team 746

18.1.128 Aug 06, 2019: Healthcare Veteran Kristine Johnson to join MRI Interventions’ board of directors 747

18.1.129 Aug 05, 2019: REVA receives additional interim funding 747

18.1.130 Aug 05, 2019: Orthofix names Jon Serbousek to Succeed CEO 747

18.1.131 Aug 05, 2019: CytoSorbents announces amendment to loan agreement with Bridge Bank, receives an additional $5 million cash from new term loan 748

18.1.132 Jul 31, 2019: New imaging method is more effective at detecting prostate cancer recurrence than standard scan 749

18.1.133 Jul 31, 2019: AngioDynamics announces appointment of former Johnson & Johnson executive Karen Licitra to its Board of Directors 750

18.1.134 Jul 31, 2019: GE Announces CFO Leadership Transition 751

18.1.135 Jul 30, 2019: Certara introduces version

19.6 of Its D360 scientific informatics platform 752

18.1.136 Jul 25, 2019: Cardiovascular Systems announces former U.S. congressman Erik Paulsen joins board of directors 753

18.1.137 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 753

18.1.138 Jul 24, 2019: Julie Stephenson joins BioSig as Senior Director of Clinical Affairs 754

18.1.139 Jul 24, 2019: OSI Systems receives $10 million in orders for patient monitoring systems and accessories 755

18.1.140 Jul 24, 2019: AliveCor appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board 755

18.1.141 Jul 18, 2019: Harvard Bioscience names Michael Rossi Chief Financial Officer 755

18.1.142 Jul 18, 2019: Olivier Chaudoir joins BioSig as director of marketing 756

18.1.143 Jul 17, 2019: Micron Solutions hires new CFO 756

18.1.144 Jul 16, 2019: Cardinal Health appoints Stephen Mason to lead medical segment 757

18.1.145 Jul 11, 2019: Ablative Solutions announces appointment of Kate Rumrill as president and chief executive officer 757

18.1.146 Jul 11, 2019: Manasi Patwardhan joins BioSig as director of strategic planning 758

18.1.147 Jul 10, 2019: Synchronized cardiovascular support now ready for the market 759

18.1.148 Jul 10, 2019: Acutus Medical announces addition of Scott Huennekens as executive chairman of the board 759

18.1.149 Jul 09, 2019: Cleveland Clinic names Samir Kapadia, M.D., Chairman of the Department of Cardiovascular Medicine 760

18.1.150 Jul 08, 2019: Cardinal Health: Departure of CFO 761

18.1.151 Jul 08, 2019: James Green named President and CEO of Harvard Bioscience 761

18.1.152 Jul 08, 2019: ICU Medical CFO announces intention to retire from CFO role after close of FY19 762

18.1.153 Jul 03, 2019: Britta Lesaux appointed president & CEO Philips Canada 762

18.2 Financial Announcements 763

18.2.1 Apr 29, 2020: Ge announces first quarter 2020 results 763

18.2.2 Apr 27, 2020: Sanmina reports second quarter financial results 763

18.2.3 Apr 16, 2020: Abbott reports first-quarter 2020 results 763

18.2.4 Mar 10, 2020: CerTest Biotec and BD announce COVID-19 diagnostic test 765

18.2.5 Mar 10, 2020: InspireMD announces fourth quarter and year-end 2019 financial results 766

18.2.6 Mar 09, 2020: Organogenesis Holdings reports fourth quarter and fiscal year 2019 financial results; Introduces fiscal year 2020 revenue guidance 768

18.2.7 Mar 05, 2020: Relay Medical announces completion of Pharmatrac API Development; now able to service telemedicine platforms and medication management applications 772

18.2.8 Mar 03, 2020: Semler reports record fourth quarter and year end 2019 financial results 774

18.2.9 Feb 27, 2020: New study shows vision rehab treatment effective for stroke and injury related blindness 775

18.2.10 Feb 27, 2020: ICU Medical announces fourth quarter 2019 results 777

18.2.11 Feb 26, 2020: Harvard Bioscience announces fourth quarter 2019 financial results 777

18.2.12 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 779

18.2.13 Feb 23, 2020: WuXi Biologics congratulates Immutep on positive interim data for IMP-321 780

18.2.14 Feb 20, 2020: Teleflex reports fourth quarter and full year 2019 results; provides 2020 guidance 782

18.2.15 Feb 20, 2020: Integer Holdings reports results for fourth quarter and full year 2019 784

18.2.16 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance 785

18.2.17 Feb 19, 2020: Endologix reports fourth quarter and fiscal year 2019 financial results 787

18.2.18 Feb 13, 2020: NCCN guidelines for breast cancer updated for lymphedema 788

18.2.19 Feb 13, 2020: CryoLife reports fourth quarter and full year 2019 financial results 789

18.2.20 Feb 13, 2020: Shockwave Medical reports fourth quarter and full year 2019 financial results and provides full year 2020 financial outlook 790

18.2.21 Feb 12, 2020: Lakewood Ranch Medical Center First to Deploy 7D Surgical’s Machine-Vision Image Guided Surgery (MvIGS) Platform in the Greater Tampa Bay Area 791

18.2.22 Feb 12, 2020: ClearPoint Neuro reports 53% increase in 2019 revenue 793

18.2.23 Feb 07, 2020: Onkos Surgicals launches magnesium bone scaffolding technology 794

18.2.24 Feb 06, 2020: BD announces results for 2020 first fiscal quarter; lowers fiscal 2020 guidance 796

18.2.25 Feb 06, 2020: Abiomed announces Q3 FY 2020 revenue of $222 million and

31.7% operating margin 797

18.2.26 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020 799

18.2.27 Feb 06, 2020: LeMaitre Vascular Announces Q4 2019 Financial Results 800

18.2.28 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 800

18.2.29 Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results 802

18.2.30 Feb 04, 2020: McKesson reports fiscal 2020 third quarter results 803

18.2.31 Jan 30, 2020: UTMD reports audited year 2019 and fourth quarter financial performance 804

18.2.32 Jan 29, 2020: EDAP announces sale of Robotic Focal One HIFU Device to University of Miami 811

18.2.33 Jan 29, 2020: GE Announces fourth quarter 2019 results 812

18.2.34 Jan 28, 2020: Beckman Coulter’s Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance 813

18.2.35 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook 813

18.2.36 Jan 27, 2020: 90% of patients can’t use inhalers correctly, digital inhaler CapMedic receives FDA clearance to change that 815

18.2.37 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 816

18.2.38 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020 817

18.2.39 Jan 21, 2020: EOS imaging announces first installation of EOSedge in North America 819

18.2.40 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 820

18.2.41 Jan 14, 2020: CytoSorbents reports preliminary 2019 financial results and issues stockholder letter 821

18.2.42 Jan 13, 2020: Abiomed announces preliminary Q3 FY 2020 revenue of $222 million, up 10% over prior year 824

18.2.43 Jan 13, 2020: Organogenesis Holdings reports preliminary revenue results for the fourth quarter and fiscal year 2019 825

18.2.44 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance 826

18.2.45 Jan 09, 2020: SI-BONE reports preliminary unaudited revenue for fourth quarter and full year 2019 and provides full year 2020 revenue guidance 826

18.2.46 Jan 09, 2020: T2 Biosystems announces preliminary fourth quarter 2019 financial results 827

18.2.47 Jan 07, 2020: Olympus remains committed to endoscopic ultrasound (EUS) through continued U.S. distribution of ARIETTA 850 828

18.2.48 Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results 829

18.2.49 Dec 23, 2019: iRhythm Technologies files quarterly report on form 10-Q for third quarter 2019 and updates guidance for full year 2019 830

18.2.50 Dec 20, 2019: Osprey Medical: Fourth Quarter Update 831

18.2.51 Dec 19, 2019: Interscope announces new FDA clearance of the EndoRotor, for use in airway procedures including in interventional pulmonology 832

18.2.52 Dec 17, 2019: New grading system to predict future vision of infantile nystagmus patients 834

18.2.53 Dec 16, 2019: Sysmex Inostics announces first results of tissue-independent liquid biopsy for early stage breast cancer mutation characterization and monitoring using ultra-sensitive SafeSEQ Technology 836

18.2.54 Dec 14, 2019: Myriad’s Polygenic Risk Score personalizes risk of breast cancer for woman with a genetic mutation in important breast cancer genes 839

18.2.55 Dec 10, 2019: InspireMD announces planned leadership transition 841

18.2.56 Dec 09, 2019: ImaginAb initiates phase II clinical trial at Penn Medicine 843

18.2.57 Dec 01, 2019: Hyland Healthcare launches new products and updates at RSNA 2019 845

18.2.58 Nov 21, 2019: PAVmed reports third quarter 2019 financial results and provides business update 848

18.2.59 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 852

18.2.60 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 854

18.2.61 Nov 14, 2019: Vaso Corporation reports financial results for third quarter 2019 855

18.2.62 Nov 13, 2019: San Gorgonio Memorial Hospital selects Allscripts electronic health record suite for community hospitals 856

18.2.63 Nov 13, 2019: Micron Solutions reports 2019 third quarter results 857

18.2.64 Nov 12, 2019: T2 Biosystems reports third quarter 2019 financial highlights and provides corporate update 858

18.2.65 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 859

18.2.66 Nov 12, 2019: Vermillion reports third quarter 2019 financial results 860

18.2.67 Nov 12, 2019: Organogenesis Holdings reports third quarter and nine months of 2019 financial results 862

18.2.68 Nov 11, 2019: ICU Medical announces third quarter 2019 results 865

18.2.69 Nov 11, 2019: SI-BONE reports third quarter 2019 financial results and updates full-year 2019 revenue guidance 865

18.2.70 Nov 07, 2019: Salimetrics releases new Salivary Osteocalcin Test to support interdisciplinary research 866

18.2.71 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020 868

18.2.72 Nov 07, 2019: Shockwave medical reports third quarter 2019 financial results 869

18.2.73 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 870

18.2.74 Nov 06, 2019: Bellerophon provides business update and reports third quarter 2019 financial results 871

18.2.75 Nov 06, 2019: Endologix reports third quarter 2019 financial results 873

18.2.76 Nov 05, 2019: CytoSorbents reports third quarter 2019 financial results 874

18.2.77 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 878

18.2.78 Nov 05, 2019: Harvard Bioscience announces third quarter financial results 880

18.2.79 Nov 05, 2019: iRhythm Technologies announces third quarter 2019 financial results 881

18.2.80 Nov 05, 2019: CHF Solutions announces third quarter financial results and provides company update 882

18.2.81 Nov 04, 2019: Intricon reports third quarter 2019 results 883

18.2.82 Nov 01, 2019: Atrion reports third quarter 2019 results 884

18.2.83 Oct 31, 2019: DEP gemcitabine outperforms Gemzar in human pancreatic cancer model 884

18.2.84 Oct 31, 2019: Teleflex reports third quarter 2019 results 887

18.2.85 Oct 31, 2019: Abiomed announces Q2 FY 2020 revenue of $205 million and

29.4% operating margin 889

18.2.86 Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance 890

18.2.87 Oct 30, 2019: Cue Biopharma announces upcoming scientific presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting 891

18.2.88 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 893

18.2.89 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 894

18.2.90 Oct 30, 2019: GE announces third quarter 2019 results 895

18.2.91 Oct 30, 2019: CONMED announces third quarter 2019 financial results 896

18.2.92 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 896

18.2.93 Oct 30, 2019: AtriCure reports third quarter 2019 financial results 899

18.2.94 Oct 30, 2019: Exelixis announces third quarter 2019 financial results and provides corporate update 900

18.2.95 Oct 30, 2019: Semler reports record third quarter and year-to-date 2019 financial results 903

18.2.96 Oct 29, 2019: Soliton’s recent positive data increases potential fibrotic indications 904

18.2.97 Oct 29, 2019: Stryker reports third quarter 2019 operating results 906

18.2.98 Oct 29, 2019: Cardiovascular Systems reports fiscal 2020 first-quarter financial results 907

18.2.99 Oct 29, 2019: Silk Road Medical reports third quarter 2019 financial results 909

18.2.100 Oct 29, 2019: Osprey Medical: 48% increase in DyeVert third quarter unit sales 910

18.2.101 Oct 28, 2019: FDA Approves Medicines360’s LILETTA (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Six Years, the Longest Approved Duration of Use of Any Hormonal IUDs 911

18.2.102 Oct 28, 2019: Orthofix reports third quarter 2019 results 913

18.2.103 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results 914

18.2.104 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 915

18.2.105 Oct 24, 2019: UTMD reports financial performance for third quarter and nine months of year 2019 917

18.2.106 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 919

18.2.107 Oct 23, 2019: Edwards Lifesciences reports third quarter results 921

18.2.108 Oct 23, 2019: LeMaitre Vascular announces Q3 2019 financial results 923

18.2.109 Oct 16, 2019: Fidmi Medical receives FDA regulatory clearance for low-profile Enteral Feeding Device 924

18.2.110 Oct 16, 2019: Abbott reports third-quarter 2019 results 926

18.2.111 Oct 15, 2019: NeuroMetrix announces updates to Quell

2.0 commercial strategy 928

18.2.112 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 931

18.2.113 Oct 03, 2019: AngioDynamics reports fiscal 2020 first quarter financial results 932

18.2.114 Sep 30, 2019: AI System Accurately Detects Key Findings in Chest X-Rays of Pneumonia Patients Within 10 Seconds; Study Finds Promise of Faster Treatment 933

18.2.115 Sep 28, 2019: GRAIL to present new data in late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2019 Congress 936

18.2.116 Sep 25, 2019: Katerzia, the first and only amlodipine oral suspension, 1 mg/mL, is now commercially available for pediatric patients 6 years of age and older 938

18.2.117 Sep 18, 2019: CLS Therapeutics receives Orphan Drug Designation for CLS-014 for the treatment of Pancreatic Cancer 940

18.2.118 Sep 16, 2019: Saluda Medical announces European commercial launch of Evoke, the first and only ECAP-Controlled, Closed-Loop SCS System for chronic pain relief 941

18.2.119 Sep 16, 2019: Hamilton introduces the ID Nimbus Presto for automated high-volume nucleic acid extractions 943

18.2.120 Sep 12, 2019: Optinose announces $150 million debt financing from Pharmakon 945

18.2.121 Sep 05, 2019: PAVmed reports second quarter 2019 financial results and provides business update 946

18.2.122 Sep 02, 2019: Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension 951

18.2.123 Aug 28, 2019: CytoSorbents highlights recent published studies on CytoSorb 952

18.2.124 Aug 26, 2019: Bio-Path announces patient dosing in amended phase 2 prexigebersen trial in Acute Myeloid Leukemia 955

18.2.125 Aug 26, 2019: OSI Systems reports fiscal 2019 fourth quarter and full year financial results 956

18.2.126 Aug 15, 2019: Micron Solutions reports 2019 second quarter results 957

18.2.127 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 957

18.2.128 Aug 14, 2019: Osprey Medical: First half revenues increase 54% to US$1.8 million 959

18.2.129 Aug 14, 2019: Vaso reports financial results for second quarter 2019 960

18.2.130 Aug 13, 2019: Immunovant appoints Robert K. Zeldin, M.D. as chief medical officer and W. Bradford Middlekauff, J.D. as general counsel 962

18.2.131 Aug 13, 2019: CVD Reports Second Quarter 2019 Results 964

18.2.132 Aug 09, 2019: Organogenesis Holdings reports second quarter and first half 2019 financial results 965

18.2.133 Aug 08, 2019: Bellerophon provides business update and reports second quarter 2019 financial results 967

18.2.134 Aug 08, 2019: Corindus reports second quarter 2019 results 969

18.2.135 Aug 08, 2019: Cardinal Health reports fourth quarter and full year results for fiscal year 2019 970

18.2.136 Aug 08, 2019: Endologix reports second quarter 2019 financial results 972

18.2.137 Aug 08, 2019: Stereotaxis reports 2019 second quarter financial results 973

18.2.138 Aug 08, 2019: Vermillion reports second quarter 2019 financial results 974

18.2.139 Aug 07, 2019: Neovasc announces second quarter 2019 financial results 975

18.2.140 Aug 07, 2019: USRM posts earnings for second quarter 2019 978

18.2.141 Aug 07, 2019: Atrion reports second quarter results 979

18.2.142 Aug 07, 2019: ICU Medical announces second quarter 2019 results 979

18.2.143 Aug 06, 2019: CHF Solutions announces 53 percent increase in revenues for second quarter 2019 over previous year and 38 percent increase from Q1 2019 980

18.2.144 Aug 06, 2019: IntriCon reports second quarter 2019 results 980

18.2.145 Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance 981

18.2.146 Aug 06, 2019: Cardiovascular Systems reports fiscal 2019 fourth-quarter financial results 983

18.2.147 Aug 06, 2019: MRI Interventions reports 58% increase in 2019 second quarter revenue 984

18.2.148 Aug 06, 2019: CytoSorbents reports record second quarter 2019 financial results 986

18.2.149 Aug 06, 2019: SI-BONE reports second quarter 2019 financial results 987

18.2.150 Aug 06, 2019: Penumbra reports second quarter 2019 financial results 987

18.2.151 Aug 05, 2019: Shockwave Medical reports second quarter 2019 financial results 988

18.2.152 Aug 05, 2019: Orthofix reports second quarter 2019 results 989

18.2.153 Aug 01, 2019: Teleflex reports second quarter 2019 results 989

18.2.154 Aug 01, 2019: Abiomed announces Q1 FY 2020 revenue of $208 million and

29.2% operating margin 992

18.2.155 Aug 01, 2019: Integer Holdings reports second quarter 2019 results 993

18.2.156 Jul 31, 2019: McKesson reports fiscal 2020 first-quarter results 994

18.2.157 Jul 31, 2019: iRhythm Technologies Announces Second Quarter 2019 Financial Results 995

18.2.158 Jul 31, 2019: GE Announces Second Quarter 2019 Results 996

18.2.159 Jul 31, 2019: CONMED announces second quarter 2019 financial results 997

18.2.160 Jul 31, 2019: Exelixis announces second quarter 2019 financial results and provides corporate update 998

18.2.161 Jul 31, 2019: Surmodics reports third quarter fiscal 2019 results and raises fiscal 2019 revenue and EPS guidance 1001

18.2.162 Jul 31, 2019: Nuvectra reports second quarter 2019 financial results 1002

18.2.163 Jul 31, 2019: Avinger reports 26% sequential revenue growth in second quarter 2019 1002

18.2.164 Jul 30, 2019: Utah Medical Products reports financial performance for second quarter 2019 1004

18.2.165 Jul 30, 2019: AtriCure reports second quarter 2019 Financial Results 1009

18.2.166 Jul 30, 2019: T2 Biosystems reports second quarter 2019 financial results and provides corporate update 1010

18.2.167 Jul 30, 2019: CryoLife reports second quarter 2019 financial results 1013

18.2.168 Jul 29, 2019: Lourdes Felix, Chief Operating Officer and Chief Financial Officer of BioCorRx discusses the launch of the UnCraveRx Virtual App in a new interview at SmallCapVoice.com 1013

18.2.169 Jul 29, 2019: Sanmina posts results for Q3 fiscal 2019 1013

18.2.170 Jul 29, 2019: Silk Road Medical reports second quarter 2019 financial results and raises 2019 outlook 1014

18.2.171 Jul 26, 2019: Semler reports record second quarter and first half 2019 financial results 1015

18.2.172 Jul 25, 2019: Interface reports second quarter 2019 results 1015

18.2.173 Jul 25, 2019: Baxter reports second-quarter 2019 results 1017

18.2.174 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 1019

18.2.175 Jul 25, 2019: Harvard Bioscience announces quarter ended June 30, 2019 financial results 1021

18.2.176 Jul 25, 2019: Stryker reports second quarter 2019 operating results 1022

18.2.177 Jul 24, 2019: Integra LifeSciences reports second quarter 2019 financial results 1023

18.2.178 Jul 24, 2019: LeMaitre Vascular announces Q2 2019 financial results 1024

18.2.179 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 1024

18.2.180 Jul 23, 2019: CEL-SCI’s scientific review on Inflammatory Disease therapies published in peer reviewed Journal “International Immunopharmacology” 1026

18.2.181 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019 1028

18.2.182 Jul 18, 2019: Paragon launches new firm with focus on AI diagnostics 1029

18.2.183 Jul 18, 2019: Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in Amyotrophic Lateral Sclerosis 1031

18.2.184 Jul 17, 2019: Abbott reports second-quarter 2019 results 1033

18.2.185 Jul 16, 2019: SynDaver receives patent for its Cricothyroidotomy and Nasogastric tube medical simulation trainer 1036

18.2.186 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 1038

18.2.187 Jul 15, 2019: VitaFlow Transcatheter Aortic Valve and delivery system receives approval 1039

18.2.188 Jul 12, 2019: New test could reduce premature births by up to 30 per cent 1041

18.2.189 Jul 11, 2019: Opsens – Q3 2019 – Record Quarterly FFR Revenues of $5.2 M, Up 49% 1044

18.2.190 Jul 10, 2019: New technology improves atrial fibrillation detection after stroke 1044

18.2.191 Jul 10, 2019: AngioDynamics reports fiscal 2019 fourth quarter and full-year financial results 1046

18.2.192 Jul 08, 2019: Total Support for a Series of Urine Testing Processes New Release of a Urinary Sediment Analyzer 1048

18.3 Government and Public Interest 1051

18.3.1 Jun 30, 2020: CMS proposes to expand coverage policy for transcatheter edge-to-edge repair (TEER) for patients with mitral valve regurgitation 1051

18.3.2 Apr 23, 2020: Expert available to comment on urgency of scaling public health workforce to conduct COVID-19 Testing and Contact Tracing 1052

18.3.3 Apr 08, 2020: CHF Solutions convene physicians to discuss cardio-pulmonary-renal management of COVID-19 patients 1052

18.3.4 Jan 29, 2020: IDTechEx Research: Remote Patient Monitoring is the Future of Cardiovascular Disease Management 1053

18.3.5 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 1054

18.3.6 Jan 27, 2020: Dr. Rajamannan sends over to the FDA commissioner the US senate finance investigation files to help the FDA’s review of newly discovered design control study in Chicago 1054

18.3.7 Jan 22, 2020: Newly minted FDA commissioner Dr. Stephen Hahn receives Minneapolis FDA affidavit from Dr. Nalini Rajamannan regarding FDA design control study using a non-exempt medical device 1056

18.3.8 Jan 13, 2020: Peripheral percutaneous transluminal angioplasty (PTA) and specialty catheters – premarket notification (510(k)) submissions 1057

18.3.9 Nov 12, 2019: RedHill Biopharma announces publication of RHB-102 gastroenteritis phase 3 study results in JAMA 1057

18.3.10 Nov 06, 2019: New technique lays foundation for regenerative cardiac therapies 1058

18.3.11 Sep 25, 2019: Alphatec announces commercial launch of IdentiTi TLIF Posterior Oblique Porous Titanium Interbody Implant System 1059

18.3.12 Sep 16, 2019: Xstrahl introduces image-guidance for superficial and orthovoltage radiotherapy systems 1060

18.3.13 Sep 16, 2019: New 3D technology can repair aneurysms previously deemed inoperable 1061

18.3.14 Sep 09, 2019: Roche secures two EC approvals for Tecentriq in lung cancer 1062

18.3.15 Sep 09, 2019: Theravance Biopharma reports positive results from phase 1 clinical trial of TD-8236, an investigational, lung-selective, inhaled Pan-Janus Kinase (JAK) inhibitor for inflammatory lung diseases 1064

18.3.16 Sep 05, 2019: New caregiver-reported data further validate the use of the aberrant behavior checklist community: FXS specific (ABC-CFXS) subscales to assess core behavioral symptoms of Fragile X Syndrome (FXS) 1066

18.3.17 Aug 29, 2019: Parker Waichman LLP and The Drakulich Firm File TDF Lawsuit 1068

18.3.18 Aug 27, 2019: Artificial intelligence could use EKG data to measure patient’s overall health status 1070

18.3.19 Aug 07, 2019: Treatment of Peripheral Arterial Disease with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents potentially associated with increased mortality 1071

18.3.20 Aug 06, 2019: Paper heart valves help scientists study calcifying diseases 1072

18.3.21 Aug 05, 2019: Paper trail leads to heart valve discoveries 1073

18.3.22 Aug 01, 2019: FRESH 3D printing used to rebuild functional components of human heart 1074

18.4 Legal And Regulatory 1075

18.4.1 Apr 24, 2020: FDA lifts injunction on manufacture and distribution of Philips’ defibrillators in the US 1075

18.4.2 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures 1075

18.4.3 Jan 28, 2020: Imricor receives CE Mark approval for Vision-MR Ablation Catheter 1076

18.4.4 Jan 23, 2020: Vulnerability disclosure regarding GE Healthcare monitoring products 1077

18.4.5 Jan 15, 2020: Governor Pritzker receives FDA testimonies on non-exempt medical device as FDA Delays to Not Inform the patients across the United States as confirmed by Dr. Rajamannan at Most Sacred Heart of Jesus Cardiology and Valvular Institute 1078

18.4.6 Jan 13, 2020: Cortexyme announces the initiation of an open-label extension study for the GAIN Trial of COR388 in Alzheimer’s disease 1079

18.4.7 Jan 13, 2020: MRI Interventions to change corporate name to ClearPoint Neuro 1080

18.4.8 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter 1080

18.4.9 Dec 09, 2019: Laboratory to pay $26.67 million to settle allegations of kickbacks to physicians 1081

18.4.10 Dec 05, 2019: Nozin Nasal Sanitizer Programs reduce MRSA infections, lower healthcare costs say hospital clinicians 1082

18.4.11 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International 1083

18.4.12 Nov 26, 2019: MiMedx announces Securities and Exchange Commission Settlement 1083

18.4.13 Nov 26, 2019: SEC charges biotech company and executives with accounting fraud 1084

18.4.14 Nov 19, 2019: FDA-approved devices that help Keep the heart beating 1084

18.4.15 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 1085

18.4.16 Nov 10, 2019: Legal-Bay Pre Settlement funding focusing on faulty IVC Filter potential settlements 1086

18.4.17 Nov 08, 2019: Medacta, Geisinger extend lifetime guarantee to revision knee surgeries 1086

18.4.18 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits 1088

18.4.19 Oct 23, 2019: South Bend Clinic invests additional $5.6 million in NextGen Healthcare Solutions to improve delivery of value-based care 1089

18.4.20 Oct 17, 2019: Thermo Fisher Scientific launches new external molecular control panel for the analytical evaluation of BCR-ABL Test Methods 1090

18.4.21 Oct 07, 2019: New test for thyroid cancer could prevent unnecessary surgery 1090

18.4.22 Sep 30, 2019: Mallinckrodt finalizes settlement to resolve “Track 1” opioid cases with the Ohio Counties of Cuyahoga and Summit 1092

18.4.23 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker 1092

18.4.24 Sep 25, 2019: Preclincal results of Baoyuan’s next-generation ROS1/NTRK inhibitor AB-106 published in Nature Communications 1093

18.4.25 Sep 23, 2019: Announcing Nexelis, a new name with long experience in the world of immuno-science 1094

18.4.26 Sep 11, 2019: Memo Therapeutics nominates its first human-derived monoclonal antibody to enter preclinical development 1094

18.4.27 Sep 06, 2019: Mallinckrodt announces settlement in principle to resolve “Track 1″ opioid cases with the Ohio Counties of Cuyahoga and Summit 1095

18.4.28 Sep 04, 2019: LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 in Cardinal Health to contact the firm 1095

18.4.29 Sep 04, 2019: Faruqi & Faruqi Encourages Investors who suffered losses exceeding $50,000 in Mallinckrodt to contact the Firm 1095

18.4.30 Sep 03, 2019: Mallinckrodt announces completion of previously disclosed Settlement Agreement with U.S. Department of Justice on Legacy Questcor sales and marketing activities 1096

18.4.31 Aug 12, 2019: Lead plaintiff deadline alert: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 In Cardinal Health to contact the firm 1096

18.4.32 Aug 07, 2019: Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed against Abiomed and encourages Abiomed investors to contact the firm 1097

18.4.33 Jul 25, 2019: BD Statement on Georgia facilities 1098

18.5 Other Significant Developments 1098

18.5.1 Jun 18, 2020: Clinical experts discuss fluid management strategies in critically ill covid-19 patients during CHF solutions webinar 1098

18.5.2 Jun 08, 2020: GE reopens prior debt offerings for $3 Billion in proceeds to enhance and extend liquidity 1099

18.5.3 May 29, 2020: Per FDA Guidance, Medtronic temporarily modifies several cardiopulmonary product indications for longer duration use in ECMO Therapy to address COVID-19 1100

18.5.4 Apr 17, 2020: BioSig issues April 2020 shareholder update letter 1101

18.5.5 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 1101

18.5.6 Apr 02, 2020: SI-BONE provides business update in response to covid-19 pandemic 1102

18.5.7 Mar 30, 2020: ERT’s at-home cardiac safety assessment ensures clinical trial continuity 1103

18.5.8 Mar 25, 2020: Abiomed’s response to the COVID-19 pandemic 1103

18.5.9 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol 1105

18.5.10 Mar 04, 2020: Neovasc updates investors at SVB Leerink 9th Annual Global Healthcare Conference 1106

18.5.11 Feb 28, 2020: Long Beach Medical Center only Southern California site participating in AFib clinical trial 1107

18.5.12 Feb 27, 2020: BIOLIFE4D CSO Dr. Ravi Birla publishes paper in prestigious APL bioengineering scholarly journal 1108

18.5.13 Feb 06, 2020: Hillcrest Medical Center adds cardiology to Sectra Enterprise Imaging Solution 1109

18.5.14 Feb 03, 2020: 3D Systems expands Sanmina relationship to provide plastic printer manufacturing — driving greater quality, availability, and reliability while improving 3d systems’ cost structure 1109

18.5.15 Jan 31, 2020: Pitt’s Center for Medical Innovation awards three novel biomedical projects with $47,500 in Round 2 2019 Pilot Funding 1110

18.5.16 Jan 30, 2020: ICU Medical invests $13 million in new operations and the installation of 4,000 Solar Panels 1111

18.5.17 Jan 27, 2020: LexaGene’s Analyzer is designed to detect pathogens such as the Novel Coronavirus to help avert a pandemic 1112

18.5.18 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 1113

18.5.19 Jan 21, 2020: Cook Medical awarded new contract with Veterans Affairs for endovascular medical devices 1114

18.5.20 Jan 16, 2020: Expert Alert: Robotic repair offers benefits for many patients with leaky mitral valve 1114

18.5.21 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 1115

18.5.22 Jan 07, 2020: Jant Pharmacal is awarded contract from Vizient 1115

18.5.23 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax 1116

18.5.24 Dec 19, 2019: The Children’s Heart Foundation funds new research into congenital heart defects 1116

18.5.25 Dec 12, 2019: McKesson selected by Department of Veterans Affairs as prime pharmaceutical provider 1117

18.5.26 Dec 11, 2019: Innovation Hub provides funding to seven entrepreneurial teams 1117

18.5.27 Dec 03, 2019: New Uscom US Sales and Marketing Expansion 1119

18.5.28 Nov 21, 2019: $3.6 million Helmsley charitable trust grant to fund life-saving new technology for south dakota first responders 1120

18.5.29 Nov 18, 2019: Biosense Webster launches a two-pronged initiative to tackle the new millennium epidemic of Atrial Fibrillation 1121

18.5.30 Nov 14, 2019: Precipio wins $750,000 Pharma Project 1122

18.5.31 Nov 14, 2019: Bioclinica Medical Imaging achieves milestone with celebration of primary endpoint data analysis contributions to 200 FDA approvals 1122

18.5.32 Nov 13, 2019: Proximo Medical expands portfolio with PEDRA Technology 1123

18.5.33 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 1123

18.5.34 Nov 12, 2019: Cardiac Resynchronization therapy benefits cancer survivors with heart failure 1124

18.5.35 Nov 08, 2019: Crizotinib in c-MET- or ROS1-positive Non-Small Cell Lung Cancer 1126

18.5.36 Nov 04, 2019: Ernie Green Industries and Gilero announce business realignment 1127

18.5.37 Nov 01, 2019: Stereotaxis and ADAS 3D combine robotic precision and advanced preoperative substrate mapping to treat cardiac arrhythmias 1127

18.5.38 Oct 30, 2019: Veracyte announces new data characterizing genomic alterations in thyroid cancer to be presented at 89th Annual Meeting of the American Thyroid Association 1128

18.5.39 Oct 28, 2019: NIH grants UVA researchers $2.7M that could lead to precision treatment for deadly heart plaque 1129

18.5.40 Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia 1130

18.5.41 Oct 17, 2019: Fujifilm Sonosite Signs agreement with Intelligent Ultrasound Group to develop clinician training 1130

18.5.42 Oct 17, 2019: Rite Aid awards $50,000 to UC Davis Children’s Hospital, money will fund Project Adam 1131

18.5.43 Oct 17, 2019: Intelligent Ultrasound Group: Agreement with FUJIFILM SonoSite to develop clinician training 1132

18.5.44 Oct 14, 2019: UH Rainbow Babies & Children’s Hospital receives $3 million to establish Pediatric Disaster Care Center of Excellence 1132

18.5.45 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica 1133

18.5.46 Oct 01, 2019: LUMEDX announces industry partnership with MedAxiom 1134

18.5.47 Oct 01, 2019: Cellular-connected Drones to Deliver Life-saving Emergency Defibrillators Following Ground-breaking Canadian Trial 1135

18.5.48 Sep 18, 2019: Yourgene Health announces launch of DPYD chemotoxicity diagnostic assay 1136

18.5.49 Sep 17, 2019: Southwest Diagnostic Imaging Center improves care for patients by successfully deploying royal enterprise care management 1137

18.5.50 Sep 17, 2019: AdventHealth, Moffitt Cancer Center join forces to improve cancer care for Floridians 1138

18.5.51 Sep 16, 2019: Proximo Medical named the commercialization partner for Biotronik peripheral vascular intervention portfolio in select U.S. Markets 1139

18.5.52 Sep 11, 2019: CryoLife enters into distribution agreement with Endospan 1139

18.5.53 Sep 10, 2019: Bioclinica outlines next phase of growth and global expansion 1141

18.5.54 Sep 09, 2019: Harvard Bioscience announces strategic action plan and financial targets 1142

18.5.55 Sep 09, 2019: Cesca Therapeutics and ThermoGenesis announce major global distribution agreement for the company’s X-Series products 1143

18.5.56 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 1143

18.5.57 Aug 26, 2019: Nuvectra exploring strategic options to enhance shareholder value 1144

18.5.58 Aug 21, 2019: Noninvasive modeling technology aims to better assess risk of heart attack 1144

18.5.59 Aug 13, 2019: Precipio Pathology sales metrics demonstrate continuous improvement in Q2 2019 1145

18.5.60 Aug 07, 2019: Startups Qr8 Health and Enspire DBS Therapy become newest tenants at Global Center for Health Innovation 1146

18.5.61 Aug 02, 2019: Mayo Clinic tests AI to detect atrial fibrillation 1147

18.5.62 Aug 02, 2019: 3D printing the human heart 1148

18.5.63 Aug 01, 2019: Access Scientific unveils partnership with smiths medical to sell access’ Powerwand product lines and completion of a $20m capital raise 1149

18.5.64 Aug 01, 2019: NIH Grant for Cardiothoracic Surgery Awarded 1149

18.5.65 Jul 30, 2019: Starting with less-invasive procedures to restore leg blood flow as good at avoiding amputation as starting with open surgery 1150

18.5.66 Jul 22, 2019: Precipio: Global expansion efforts begin yielding results 1151

18.5.67 Jul 22, 2019: New study finds independent predictors of first pass effect in mechanical thrombectomy 1152

18.5.68 Jul 18, 2019: New studies highlight innovations in drug-eluting stent research 1152

18.5.69 Jul 15, 2019: Osprey Medical: 64% increase in DyeVert second quarter unit sales 1154

18.5.70 Jul 15, 2019: Bayfront Health Port Charlotte first in the county to perform catheter-based heart valve replacement 1155

18.5.71 Jul 10, 2019: Medtronic announces the early results of its cash tender offers for up to $5.525 billion of certain outstanding debt securities 1156

18.6 Product News 1157

18.6.1 Jun 02, 2020: Stereotaxis Robotic Technology now referenced in over 400 scientific publications 1157

18.6.2 Jun 02, 2020: Hesperos demonstrates innovative Human-on-a-Chip approach to modeling innate immune system response following tissue damage and acute inflammation 1158

18.6.3 May 14, 2020: Study examines the safety of bioabsorbable polymer against durable polymer drug-eluting stents in high-risk patients undergoing percutaneous coronary intervention 1159

18.6.4 May 12, 2020: Affera’s technology for cardiac arrhythmia treatment highlighted at the 2020 Heart Rhythm SocietyLate-Breaking Clinical Trial Session and three simultaneous publications 1160

18.6.5 May 08, 2020: First Direct Comparison of ICD Devices Underscores Benefits of the S-ICD with Better Safety Profile and Fewer Device-Related Complications 1161

18.6.6 May 07, 2020: FARAPULSE’s pioneering clinical results link compelling long-term outcomes to established safety and lesion durability data 1162

18.6.7 Mar 06, 2020: Ultra-wide field retinal imaging techniques not interchangeable 1162

18.6.8 Mar 06, 2020: ‘Real-World’ data from health systems reveal opportunities for blood pressure improvement 1163

18.6.9 Feb 17, 2020: The Latest in Pediatric Heart Disease: Benefits of Skin-to-Skin Care, Nurse-Initiated PIV training and improving cholesterol screening in high-risk patients 1164

18.6.10 Feb 04, 2020: Vizient to participate in FI HFMA & CHEF’s 2020 Managed Care Symposium 1167

18.6.11 Jan 27, 2020: CytoDyn announces CROI’s acceptance of late-breaking abstract by Dr. Jonah Sacha for use of leronlimab as PrEP 1167

18.6.12 Jan 06, 2020: Philips expands its range of consumer-focused digital health solutions at CES 2020 1169

18.6.13 Jan 02, 2020: New radiotracer offers opportunities for earlier intervention after heart attack 1171

18.6.14 Dec 16, 2019: Developing next-generation biologic pacemakers 1172

18.6.15 Dec 09, 2019: Porton Biopharma – Erwinase manufacturing schedule 1172

18.6.16 Dec 05, 2019: Fetal heart test may have predictive value for kids’ health 1173

18.6.17 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 1173

18.6.18 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference 1174

18.6.19 Nov 20, 2019: New research finds signal of decreased early post transplant survival in the new heart transplant system 1174

18.6.20 Nov 19, 2019: Orchestra BioMed to present at the Canaccord Genuity MedTech and Diagnostics Forum and the 31st Annual Piper Jaffray Healthcare Conference 1175

18.6.21 Nov 19, 2019: Improving the odds for patients with heart pumps 1175

18.6.22 Nov 15, 2019: OncoTherapy Science: Publication of a paper describing the anti-cancer effect of TOPK inhibitor OTS514 on multiple myeloma 1176

18.6.23 Nov 11, 2019: EMist to reveal a breakthrough disinfectant sprayer 1176

18.6.24 Nov 11, 2019: Artificial Intelligence examining ECGs predicts irregular heartbeat, death risk 1177

18.6.25 Oct 28, 2019: Thought Leadership & Innovation Foundation to expand its Regenerative Medicine Program through new collaboration with RenovaCare 1178

18.6.26 Oct 22, 2019: Heart MRI delivers accurate diagnosis and helps guide treatment of Cardiovascular Diseases 1180

18.6.27 Oct 14, 2019: Cheetah Medical to present at the CHEST annual meeting 2019 International Conference 1180

18.6.28 Oct 09, 2019: Vital Metrix Presented at TCT 2019 Conference 1181

18.6.29 Oct 04, 2019: McKesson launches strategic planning solution for community-based oncology customers 1181

18.6.30 Oct 02, 2019: Blood flow screening to improve detection of critical congenital heart defects in newborns 1182

18.6.31 Sep 27, 2019: Sunovion and PsychoGenics initiate DIAMOND phase 3 clinical studies for SEP-363856 in the treatment of adults and adolescents with Schizophrenia 1183

18.6.32 Sep 27, 2019: Columbia Scientists Demonstrate Power of High-Speed Microscope to Illuminate Biology at the Speed of Life 1184

18.6.33 Sep 24, 2019: Colibri Heart Valve receives a United States patent directed to a replacement heart valve that includes a dry valve sutured to a stent member 1186

18.6.34 Sep 18, 2019: Graybug Vision initiates clinical trial in macular edema secondary to diabetic macular edema or retinal vein occlusion 1187

18.6.35 Sep 09, 2019: BIOLIFE4D becomes first U.S. company to successfully demonstrate ability to 3D Bioprint a Mini Human Heart 1188

18.6.36 Sep 04, 2019: Soft robotics breakthrough manages immune response for implanted devices 1189

18.6.37 Aug 23, 2019: Researchers advance organ-on-chip technology to advance drug development 1190

18.6.38 Aug 15, 2019: The procedural and anatomical determinants of second-generation renal denervation therapy are explained by local tissue anatomy, suggesting a new paradigm for treatment optimization: CBSET data published in hypertension 1191

18.6.39 Aug 12, 2019: Evaluating blood flow is key to early diagnosis and treatment for people with critical limb ischemia 1192

18.6.40 Jul 26, 2019: Researchers develop novel imaging approach with potential to identify patients with CAD 1193

18.6.41 Jul 23, 2019: ZOLL rebrands Payor Logic Solutions as ZOLL AR Boost 1193

18.6.42 Jul 23, 2019: Type of stent affects immediate and long-term outcomes new study compares three types of stents and their effects on the safety and efficacy of the stent-coiling procedure 1194

18.6.43 Jul 16, 2019: Telehealth Technology to reduce hospital readmissions and improve outcomes for cardiac disease patients July 16, 2019 1194

18.7 Research And Development 1195

18.7.1 Oct 21, 2019: ADMA Biologics announces first commercial sales of ASCENIV 1195

18.8 Strategy And Business Planning 1196

18.8.1 Jun 30, 2020: Medical device maker Ambu and Medical Advisory Fuel Medical Group announce partnership 1196

18.8.2 Jun 25, 2020: Integer Opens New Innovative Ireland Research and Development Facility 1197

18.8.3 May 04, 2020: Venus Medtech and Opus Medical partner for TMVR and TTVR in China 1197

18.8.4 May 02, 2020: Venus Medtech and Opus Medical Therapies announce partnership for transcatheter mitral valve replacement (TMVR) and transcatheter tricuspid valve replacement (TTVR) in greater China market 1198

18.8.5 Apr 23, 2020: AliveCor and OMRON announce alivecor and omron announce global strategic alliance for comprehensive remote cardiovascular monitoring 1199

18.8.6 Feb 20, 2020: Integer acquires Israel-based medical device firm Inomec 1199

18.8.7 Feb 12, 2020: Sanford announces new Bemidji heart center 1200

18.8.8 Feb 11, 2020: IBBR Request for Proposals (RFP): GMP biomanufacturing facility available – Rockville, Maryland, USA 1201

18.8.9 Feb 11, 2020: Celerion expands clinical research to Nebraska Innovation Campus 1202

18.8.10 Feb 05, 2020: South Tulsa’s First Outpatient Cath Lab Opens 1202

18.8.11 Jan 29, 2020: Mission, TX’s first outpatient Cath Lab opens 1203

18.8.12 Jan 29, 2020: North American Partners in Anesthesia Clinicians Support Abdominal Aortic Endarterectomy at Chestnut Hill Hospital/Tower Health 1203

18.8.13 Jan 27, 2020: Soliton announces positive data from extended keloid and hypertrophic scar trials 1204

18.8.14 Jan 21, 2020: Quartz and Advocate Aurora Health announce plans to collaborate in Eastern Wisconsin 1207

18.8.15 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 1207

18.8.16 Jan 02, 2020: Natus Medical finalizes transition of Peloton business to Pediatrix Medical Group and completes signing of strategic agreement 1208

18.8.17 Dec 20, 2019: Cirtec announces plans to build Neuromodulation Center of Excellence 1208

18.8.18 Dec 06, 2019: Gilero opens new design center in Southern California 1208

18.8.19 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 1209

18.8.20 Nov 05, 2019: Opsens announces entry into structural heart market 1209

18.8.21 Nov 05, 2019: Floyd Health System and Atrium Health to join in strategic combination 1210

18.8.22 Nov 04, 2019: Atrium Health and Wake Forest one step closer to creating unique and transformative Academic Healthcare System 1210

18.8.23 Oct 30, 2019: Siemens Healthineers acquires Corindus Vascular Robotics 1212

18.8.24 Oct 29, 2019: Abbott to build medical device manufacturing facility in Indiana 1212

18.8.25 Oct 21, 2019: Ocean Insight and Triple Ring Technologies announce strategic partnership 1213

18.8.26 Oct 15, 2019: Subtle Medical receives FDA 510(k) clearance for AI-powered SubtleMR 1214

18.8.27 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 1215

18.8.28 Oct 15, 2019: BioSig opens a Technology Development Office in Rochester, MN 1215

18.8.29 Oct 15, 2019: LifeNet Health establishes world’s first dedicated regenerative medicine logistics and distribution center in Indianapolis 1216

18.8.30 Oct 12, 2019: European results from global ETNA-AF registry show low bleeding and low cardiovascular event rates in elderly NVAF Patients on LIXIANA (edoxaban) 1217

18.8.31 Oct 10, 2019: KCI introduces precision-designed PREVENA RESTOR ARTHROFORM Incision Management System for challenging surgical locations 1218

18.8.32 Oct 10, 2019: Diagnostic Centers of America improves patient care by successfully deploying the unified patient engagement platform from Royal Solutions Group 1219

18.8.33 Oct 09, 2019: Agios to Present data from AG-270 phase 1 dose-escalation study in patients with MTAP-deleted tumors in a proffered papers oral resentation and Poster Session at the AACR-NCI-EORTC International Conference 1220

18.8.34 Sep 26, 2019: CSPC Pharmaceutical Group: Drug Registration Approval of the Group’s “Glutathione for Injection” 1221

18.8.35 Sep 19, 2019: Kiniksa presents preclinical data supporting KPL-716 clinical development at the 49th Annual Meeting of the European Society of Dermatological Research 1221

18.8.36 Sep 10, 2019: Updated clinical results and new biomarker analyses presented for Daiichi Sankyo’s DS-1062 in patients with advanced NSCLC at 2019 World Conference on Lung Cancer 1222

18.8.37 Sep 06, 2019: iRhythm, Verily teams up to develop diagnostic tools for AFib 1225

18.8.38 Aug 30, 2019: Brigham Health announces September opening of comprehensive care facility in Pembroke 1226

18.8.39 Aug 28, 2019: Zoll Medical acquires AED provider Cardiac Science 1226

18.8.40 Aug 28, 2019: Samsung Collaboration with Kaiser Permanente delivers improvements in home-based cardiac rehabilitation 1226

18.8.41 Aug 22, 2019: FDA enforcement action disrupts vision test company 1227

18.8.42 Aug 07, 2019: EDAN announces Relocation and Expansion of its US Operation Hub 1229

18.8.43 Aug 06, 2019: DCRI, Cerner partner on new study using real-world data 1229

18.8.44 Jul 19, 2019: Midatech announces safety results from first in human study for injectable MidaCore Gold nano particle diabetes vaccine programme – MTX102 1230

19 Appendix 1233

19.1 Research Methodology 1234

19.1.1 Coverage 1234

19.1.2 Secondary Research 1234

19.1.3 Primary Research 1235

19.1.4 Market Modeling and Forecasting 1236

19.1.5 Company Share Analysis 1238

19.1.6 Distribution Share Analysis 1238

19.1.7 Benchmarking 1238

19.2 GlobalData Consulting 1239

19.3 Contact Us 1239

19.4 Disclaimer 1240